Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Nutrition and Cancer|November 23, 2018
Molecular Action of Herbal Antioxidants in Regulation of Cancer Growth: Scope for Novel Anticancer DrugsManjula VinayakBioscience Reports|February 16, 2011
α-Tocopherol attenuates NF-κB activation and pro-inflammatory cytokine IL-6 secretion in cancer-bearing miceRenu Sharma, Manjula VinayakLeukemia & Lymphoma|July 16, 2011
Anti-carcinogenic action of ellagic acid mediated via modulation of oxidative stress regulated genes in Dalton lymphoma bearing miceSudha Mishra, Manjula VinayakBioscience Reports|August 12, 2011
Anti-carcinogenic action of curcumin by activation of antioxidant defence system and inhibition of NF-κB signalling in lymphoma-bearing miceLaxmidhar Das, Manjula VinayakNeurochemistry International|January 1, 2020
NADPH oxidase1 inhibition leads to regression of central sensitization during formalin induced acute nociception via attenuation of ERK1/2-NFκB signaling and glial activationSanjay Kumar, Manjula VinayakInternational Immunopharmacology|March 12, 2014
Curcumin attenuates carcinogenesis by down regulating proinflammatory cytokine interleukin-1 (IL-1α and IL-1β) via modulation of AP-1 and NF-IL6 in lymphoma bearing miceLaxmidhar Das, Manjula VinayakNutrition and Cancer|February 28, 2014
Ellagic acid induces novel and atypical PKC isoforms and promotes caspase-3 dependent apoptosis by blocking energy metabolismSudha Mishra, Manjula VinayakMolecular Biology Reports|February 28, 2014
Ellagic acid inhibits PKC signaling by improving antioxidant defense system in murine T cell lymphomaSudha Mishra, Manjula VinayakLeukemia & Lymphoma|February 5, 2014
Long-term effect of curcumin down-regulates expression of tumor necrosis factor-α and interleukin-6 via modulation of E26 transformation-specific protein and nuclear factor-κB transcription factors in livers of lymphoma bearing miceLaxmidhar Das, Manjula VinayakPlos One|April 11, 2015
Long term effect of curcumin in restoration of tumour suppressor p53 and phase-II antioxidant enzymes via activation of Nrf2 signalling and modulation of inflammation in prevention of cancerLaxmidhar Das, Manjula VinayakPageof 5